A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide

Veterinary Microbiology

Volumn 125, Issue 3-4, 2007, Pages 224-231

  Wang, Jia Long ^a   Liu, Ming Qiu ^a   Han, Ji ^a   Chen, Wei Zao ^a   Cong, Wei ^a   Cheng, Gong ^a   Gao, Yan Hua ^b   Lu, Yong Gan ^b   Chen, Jiu Lian ^b   Zuo, Xiao Ping ^b   Yan, Wei Yao ^a   Zheng, Zhao Xin ^a  

^a FUDAN UNIVERSITY   (China)

^b Bio pharmacy   (China)

Author keywords

B cells; Epitopes; FMDV serotype Asia1; Immunostimulatory action; T cells

Indexed keywords

AMINO ACID; EPITOPE; IMMUNOSTIMULATING AGENT; PEPTIDE; PROTEIN VP1; PROTEIN VP2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOT AND MOUTH DISEASE ASIA1 VIRUS; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROTYPE; VACCINE PRODUCTION; VIRUS CAPSID; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELL PROLIFERATION; EPITOPES; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNIZATION; MALE; NEUTRALIZATION TESTS; VACCINES, SUBUNIT; VIRAL FUSION PROTEINS;

CAVIA; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 35348855547     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.05.033     Document Type: Article

References (33)

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., and Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337 (1989) 709-716
2. Aggarwal N., and Barnett P.V. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. J. Gen. Virol. 83 (2002) 775-782
3. Bachrach H.L. Foot-and-mouth disease virus. Ann. Rev. Microbiol. 22 (1968) 201-244
4. Baxt B., Vakharia V., Moore D.M., Franke A.J., and Morgan D.O. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J. Viral. 63 (1989) 2143-2151
5. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
6. Collen T., Pullen L., and Doel T.R. T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J. Gen. Virol. 70 (1989) 395-403
7. Collen T., Dimarchi R., and Doel T.R. A T-cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J. immunol. 146 (1991) 749-755
8. Duque H., and Baxt B. Foot-and-mouth disease virus receptors: Comparison of bovine alpha(v) integrin utilization by type A and O viruses. J. Virol. 77 (2003) 2500-2511
9. Doel T.R. Optimization of the immune response to foot-and-mouth disease vaccines. Vaccine 17 (1999) 1761-1771
10. Domingo E., Escarmis C., Baronowski E., Ruiz-Jarabo C.M., Carrillo E., and Sobrino F. Evolution of foot-and-mouth disease virus. Virus 91 (2003) 47-63
11. Filgueira Pérez M., Wigdorovitz A., Romera A., Zamorano P., Borca M.V., and Sadir A.M. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot-and-mouth disease virus O1 Campos. Virology 271 (2000) 234-239
12. Freiberg B., Höhlich B., Haas B., Saalmüller A., Pfaff E., and Marquardt O. Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amimo-terminal residues of capsid protein VP2. J. Virol. Methods 92 (2001) 199-205
13. Germain R.N. Antigen processing and presentation. In: Paul W.E. (Ed). Fundamental Immunology (1999), Lippincott-Raven Publishers, New York 287-340
14. Jackson T., Mould A.P., Sheppard D., and King A.M.Q. Integrin alpha v beta 1 is a receptor for foot-and-mouth disease virus. J. Virol. 76 (2002) 935-941
15. Jackson T., Sheppard D., Denyer M., Blakemore W., and King A.M.Q. The epithelial integrin alpha v beta 6 is a receptor for foot-and-mouth disease virus. J. Virol. 74 (2000) 4949-4956
16. Kitching R.P. Foot-and-mouth disease: current world situation. Vaccine 17 (1999) 1772-1774
17. Knowles N.J., and Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus 91 (2003) 65-80
18. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abu-Ghazaleh R., King A., and Newman J. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2 (1994) 123-139
19. Li G.J., Chen W.Z., Yan W.Y., Zhao K., Liu M.Q., Zhang J., Fei L., Xu Q.X., Sheng Z.T., Lu Y.G., and Zheng Z.X. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or β-galactosidase as a carrier of immunogenic epitopes. Virology 328 (2004) 274-281
20. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., and Parry N. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362 (1993) 566-568
21. Mackay D.K.J., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G.H., Flint M., and Ryan M.D. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine 16 (1998) 446-459
22. Mason P.W., Grubman M.J., and Baxt B. Molecular basis of pathogensis of FMDV. Virus Res. 91 (2003) 9-32
23. Mateu M.G. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38 (1995) 1-24
24. Neff S., and Baxt B. The ability of integrin alpha(v)beta(3) to function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains. J. Virol. 75 (2001) 527-532
25. Reed L.J., and Muench H.A. A simple method of estimating fifty percent end points. Am. J. Hyg 27 (1938) 493-497
26. Shen F., Chen P.D., and Walfield A.M. Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine 17 (1999) 3039-3049
27. Sorensen K.J., Madsen K.G., Madsen E.S., Salt J.S., Nqindi J., and Machay D.K.J. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB, 3ABC in ELISA using antigens expressed in baculovirus. Arch. Virol. 143 (1998) 1461-1467
28. Strohmaier K., Franze R., and Adam K.H. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59 (1982) 295-306
29. Verdaguer N., Mateu M.G., Bravo J., Domingo E., and Fita I. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in neutralizing antibody against ffot-and-mouth disease virus. J. Mol. Biol. 256 (1996) 364-376
30. Verdaguer N., Cuconati N., Valero M.L., Stuart D., Brocchi E., Andreu D., Giralt E., Domingo E., Mateu M.G., and Fita I. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J. Virol. 72 (1998) 739-748
31. Yi J.Z., Liu M.Q., Zhu C.Z., Zhang Q., Sheng Z.T., Du Q.Y., Yan W.Y., and Zheng Z.X. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pigs. Acta Biochimica et Biophysica Sinica 36 (2004) 589-596
32. Zamorano P.I., Wigdorovitz A., Filgucira D.M.P., Escribano J.M., Sadir A.M., and Borca M.V. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Vaccine 16 (1998) 558-563
33. Zhang Q., Yang Y.Q., Zhang Z.Y., Li L., Yan W.Y., Jiang W.J., Xin A.G., Lei C.X., and Zheng Z.X. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia1 for guinea pigs. Acta Virologica 46 (2002) 1-9